The U.S. Food and Drug Administration announced Wednesday it is requesting manufacturers remove all prescription and over-the-counter ranitidine drugs from the market immediately. This is the latest ...
British pharmaceutical group GSK reported Wednesday a sharp rise in annual net profit, boosted by strong sales of HIV, ...
The French pharmaceutical company Sanofi says it has reached an agreement to resolve 4,000 cases in the U.S., in which plaintiffs are linking the discontinued heartburn drug Zantac — and its active ...
WASHINGTON — The U.S. Food and Drug Administration has approved a reformulated version of ranitidine, which was sold widely under the brand name Zantac, allowing the acid-reducing drug to return to ...
WASHINGTON, D.C. – The U.S. Food and Drug Administration (FDA) is requesting that manufacturers immediately pull all prescription and over-the-counter (OTC) ranitidine drugs from the market. The ...
Drugmaker Sanofi announced on Friday a voluntary recall of the heartburn drug Zantac from all stores in the United States and Canada amid investigations into the presence of a carcinogen discovered in ...
WASHINGTON -- U.S. health officials said Friday they are investigating low levels of a potentially dangerous contaminant in the popular heartburn medication Zantac and related generic drugs. For now, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results